RE: Cathal Friel presenting on webinar now9 Jul 2020 18:10
Interesting presentation with CF always great at delivering and a good enough reason why I am in this company for the long run.
Picked up on the PrEPBiopharm Inc (USA), 62.6% owned by Open Orphan
• has a viral prophylactic with expected utility against Covid-19
On the slide. Another spin off and back to the share holders. We have a number of spin offs and cash or shares back.
Any good reason why to be in and opportunity to top up.